Affordable Access

deepdyve-link
Publisher Website

Tamoxifen treatment causes early hepatic insulin resistance.

Authors
  • Klöting, Nora1, 2, 3
  • Kern, Matthias4, 3
  • Moruzzi, Michele4, 3
  • Stumvoll, Michael1, 2, 3
  • Blüher, Matthias5, 6, 7
  • 1 Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München, University of Leipzig and University Hospital Leipzig, Liebigstr. 20, 04103, Leipzig, Germany. , (Germany)
  • 2 IFB AdiposityDiseases, University of Leipzig, Leipzig, Germany. , (Germany)
  • 3 Department of Medicine, University of Leipzig, Leipzig, Germany. , (Germany)
  • 4 German Diabetes Center, University of Leipzig, Leipzig, Germany. , (Germany)
  • 5 Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München, University of Leipzig and University Hospital Leipzig, Liebigstr. 20, 04103, Leipzig, Germany. [email protected] , (Germany)
  • 6 German Diabetes Center, University of Leipzig, Leipzig, Germany. [email protected] , (Germany)
  • 7 Department of Medicine, University of Leipzig, Leipzig, Germany. [email protected] , (Germany)
Type
Published Article
Journal
Acta diabetologica
Publication Date
Apr 01, 2020
Volume
57
Issue
4
Pages
495–498
Identifiers
DOI: 10.1007/s00592-019-01468-6
PMID: 31909433
Source
Medline
Language
English
License
Unknown
Report this publication

Statistics

Seen <100 times